| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/02/2003 | EP1268531A2 Method for the production of bacterial toxins |
| 01/02/2003 | EP1268530A1 Hepatitis b core antigen fusion proteins |
| 01/02/2003 | EP1268528A2 Human genes and expression products |
| 01/02/2003 | EP1268527A2 Nucleic acids, proteins, and antibodies |
| 01/02/2003 | EP1268526A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/02/2003 | EP1268510A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 01/02/2003 | EP1268420A1 Chemokine receptor antagonists |
| 01/02/2003 | EP1267940A1 Compounds for targeting |
| 01/02/2003 | EP1267899A2 Salmonella vaccine materials and methods |
| 01/02/2003 | EP1073452B1 Use of deltorphin for treating cytokine mediated hepatic injury |
| 01/02/2003 | EP0810282A4 Process for obtaining improved strains of trichoderma spp. |
| 01/02/2003 | EP0723592B1 Alpha-1,4-glucan lyase from a fungus infected algae, its purification, gene cloning and expression in microorganisms |
| 01/02/2003 | EP0630408B1 PRODUCTION OF $i(ASPERGILLUS NIGER CATALASE-R) |
| 01/02/2003 | EP0628074B1 In vitro activation of cytotoxic t cells |
| 01/02/2003 | EP0489119B2 Resuspendable coated magnetic particles and stable magnetic particle suspensions |
| 01/01/2003 | CN2528778Y Membrane air pocket internal light source solar photobiological reactor |
| 01/01/2003 | CN1388830A Process for prodcing carotenoid pigments |
| 01/01/2003 | CN1388829A High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 01/01/2003 | CN1388250A Process for producing L-glutaminic acid |
| 01/01/2003 | CN1388244A Technological process of preparing rare earth chromium yeast |
| 01/01/2003 | CN1388243A One brewer's yeast engineering saccharomycete strain and the production process of alcohol and ergosterin with the strain |
| 01/01/2003 | CN1388242A Method of separating and collecting bacterial cell from fermented liquid |
| 01/01/2003 | CN1097632C A mutant E. coli strain with increased succinic acid production |
| 01/01/2003 | CN1097466C Living salmonella vaccine |
| 12/31/2002 | US6501009 Expression of Cry3B insecticidal protein in plants |
| 12/31/2002 | US6500936 Glycerol culture of actinomyces |
| 12/31/2002 | US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis |
| 12/31/2002 | US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor |
| 12/31/2002 | US6500664 Growth differentiation factor-8 family nucleic acid sequences |
| 12/31/2002 | US6500663 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 12/31/2002 | US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones |
| 12/31/2002 | US6500661 Enzymatic synthesis of gdp-fucose, which can be used in fucosylation reactions; the reaction mixture comprising gdp-4-keto-6-deoxymannose, nadph, and a prokaryotic enzyme with epimerase and reductase activity |
| 12/31/2002 | US6500659 A thermostable enzyme that catalyzes the removal of arginine, phenylalanine, or methionine from the n-terminal end of peptides |
| 12/31/2002 | US6500654 Cardiac-related ankyrin-repeat protein kinase |
| 12/31/2002 | US6500653 Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins |
| 12/31/2002 | US6500648 Methods for recombinant peptide production |
| 12/31/2002 | US6500647 Recombinant expression vector which is prepared by inserting a human parathyroid hormone gene containing a urokinase-specific cleavage site into an l-arabinose inducible vector containing a phosphoribulokinase gene fragment of |
| 12/31/2002 | US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500640 Nucleic acid molecules encoding modified dorsal tissue affecting factor |
| 12/31/2002 | US6500639 DNA shuffling to produce nucleic acids for mycotoxin detoxification |
| 12/31/2002 | US6500638 Nucleotide sequences for use in the diagnosis and treatment of prostate cancer |
| 12/31/2002 | US6500636 Chimeric pre-activated transcription factors |
| 12/31/2002 | US6500467 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500463 Mixing plasticizable matrix material, liquid plasticizer, encapsulant, non-plasticizable non-gelatinized starch, and component for controlling rate of release of encapsulant under low shear and low temperature, forming into pieces, drying |
| 12/31/2002 | US6500435 Vaccine comprising at least three isolated actinobacillus pleuropneumoniae cytolysin proteins having specified amino acid sequences |
| 12/31/2002 | US6500428 Antibodies to a lymphocyte surface receptor that binds CAML and methods of use thereof |
| 12/31/2002 | US6500424 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500423 Probiotic composition comprising viable escherichia coli strain bu-230-98 atcc deposit no. 20226 (dsm 12799) and a formulation for maintaining viability of said escherichia coli strain |
| 12/31/2002 | US6500420 Agents can be used to regulate blood flow to a wound site promoting wound healing |
| 12/31/2002 | US6500419 Method for introducing and expressing RNA in animal cells |
| 12/31/2002 | US6500211 Hybrid hydrolase enzymes |
| 12/31/2002 | US6500107 Method for the concentration of fluid-borne pathogens |
| 12/31/2002 | CA2157867C High molecular weight surface proteins of non-typeable haemophilus |
| 12/31/2002 | CA2096532C New human recombinant gamma-interferon |
| 12/31/2002 | CA2069460C Methods and compositions for preparation and use of a herpes protease |
| 12/31/2002 | CA1341414C Expression vectors of hirudine, transformed cells and process for the preparation of hirudine |
| 12/27/2002 | WO2002103032A2 Catalases, nucleic acids encoding them and methods for making and using them |
| 12/27/2002 | WO2002103026A2 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments |
| 12/27/2002 | WO2002103024A2 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | WO2002103023A2 Method for producing c9-aldehydes, c9-alcohols by means of divinyl ether synthase |
| 12/27/2002 | WO2002103019A1 Peptides participating in prionization of heterogenous erf3 |
| 12/27/2002 | WO2002103018A1 Novel polypeptide and use thereof |
| 12/27/2002 | WO2002103016A2 Human tachykinin-related splice variants and compositions thereof |
| 12/27/2002 | WO2002103015A2 Abca10 transporter |
| 12/27/2002 | WO2002103010A1 Methods and materials for targeted gene disruption in actinomycete bacteria |
| 12/27/2002 | WO2002103006A1 Guanosine triphosphate-binding protein-coupled receptors |
| 12/27/2002 | WO2002103005A1 Guanosine triphosphate-binding protein-coupled receptors |
| 12/27/2002 | WO2002103002A2 Gene associated with leishmania parasite virulence |
| 12/27/2002 | WO2002102996A1 Male contraceptives |
| 12/27/2002 | WO2002102995A1 A novel microorganism of serratia family, isolation method and the preparation method of lignin lyases using this |
| 12/27/2002 | WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | WO2002102986A2 Novel human transporter proteins and polynucleotides encoding the same |
| 12/27/2002 | WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 12/27/2002 | WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102966A1 Method and device for anaerobically fermenting organic material |
| 12/27/2002 | WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102847A1 Novel ligand and dna thereof |
| 12/27/2002 | WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof |
| 12/27/2002 | WO2002102836A2 Moraxella (branhamella) catarrhalis antigens |
| 12/27/2002 | WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 12/27/2002 | WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | WO2002102318A2 Eglin c based drugs for treatment of disease |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 12/27/2002 | WO2002102235A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 12/27/2002 | WO2002095036A3 A novel intein and uses thereof |
| 12/27/2002 | WO2002091824A8 Biological-chemical fungicide compositions and methods of use |
| 12/27/2002 | WO2002086067A3 Mycobacterial sulfation pathway proteins and methods of use thereof |
| 12/27/2002 | WO2002064760A3 Expression of recombinant proteinase k from tritirachium album in yeast |
| 12/27/2002 | WO2002062973A3 Lipase variants |
| 12/27/2002 | WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals |
| 12/27/2002 | WO2002052003A3 Regulation of human calcium channel |
| 12/27/2002 | WO2002051994A3 Polypeptides |
| 12/27/2002 | WO2002040545A3 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point |
| 12/27/2002 | WO2002040515A3 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 12/27/2002 | WO2002040514A3 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 12/27/2002 | WO2002038733B1 A selectable genetic marker for use in pasteurellaceae species |